Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
August 17, 2025Open Access

Integrated multi-omic analysis reveals novel subtype-specific regulatory interactions in pediatric B-cell acute lymphoblastic leukemia

View Full Paper
Ask AI
Bookmark
Share

Authors

IPIrina PushelZCZachary ClarkLLLisa A. Lansdon

Discussion

Loading...

Member takes

Overview

Integrated analysis uncovers subtype-specific proteomic and phosphoproteomic biomarkers in pediatric leukemia, suggesting novel treatment pathways.

Key Points

  • Novel subtype-specific biomarkers were identified through multi-omic integration, highlighting key regulatory processes in pediatric B-ALL.
  • The study reveals a potential role for calcium-dependent signaling in the Ph-like B-ALL subtype, indicating new treatment avenues.
  • Analysis combined transcriptomic, proteomic, and phosphoproteomic data from pediatric B-ALL patients, revealing integrative insights into disease mechanisms.
  • Findings support enhanced precision medicine efforts, paving the way for improved treatment strategies targeting specific leukemia subtypes.

Cite This Study

Pushel et al. (2025) studied this question.

synapsesocial.com/papers/68af31ddcf1dd9ea359e7a3dhttps://doi.org/10.1101/2025.08.13.670107
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Transcriptome-based immune subtypes reveal the heterogeneity of tumor microenvironment in pediatric B-cell acute lymphocytic leukemia2025
  2. 2Prognostic Value and Immune Characterization of Genes Associated with Childhood Acute Leukemia applying Single-Cell RNA Sequencing2025
  3. 3Data-driven discovery of gene expression markers distinguishing pediatric acute lymphoblastic leukemia subtypes.2025
  4. 4A single cell multiomic approach to dissect immunophenotypic plasticity in B-cell precursor acute lymphoblastic leukemia (BCP-ALL) pediatric patients2025
  5. 5Histone-, Receptor-, and Integrin-Related Gene Products and ADAM28 as Relevant to B-Cell Acute Lymphoblastic Leukemia (B-ALL)2025